ReviewOpen access rheumatology : research and reviews2011

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations.

Marina Scolnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.